A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease
Public ClinicalTrials.gov record NCT02726386. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, International, Open-label, Safety Study of ND0612, a Solution of Levodopa/Carbidopa Delivered Via a Pump System as a Continuous Subcutaneous Infusion in Subjects With Advanced Parkinson's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, international, open-label, safety study of ND0612, a solution of levodopa/carbidopa (LD/CD) delivered via a pump system as a continuous SC infusion in subjects with advanced Parkinson's Disease (PD).
Study identification
- NCT ID
- NCT02726386
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 214 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 4, 2016 (Actual)
- Primary completion
- Sep 9, 2019 (Actual)
- Completion
- Feb 2027 (Estimated)
- Last update posted
- May 30, 2025
2016 – 2027
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Xenoscience | Phoenix | Arizona | 85004 | — |
| Clinical Trials Inc. | Little Rock | Arkansas | 72205-6421 | — |
| The Parkinsons and Movement Disorder Institute | Fountain Valley | California | 92708-5153 | — |
| Neuro Pain Medical Center | Fresno | California | 93710 | — |
| University of Colorado Denver | Aurora | Colorado | 80045 | — |
| Rocky Mountain Movement Disorders Center | Englewood | Colorado | 80113-2776 | — |
| Parkinson's Disease and Movement Disorder Center of Boca Raton | Boca Raton | Florida | 33486-2359 | — |
| MD Clinical | Hallandale | Florida | 33009 | — |
| Infinity Clinical Research, LLC | Hollywood | Florida | 33021 | — |
| University of Florida Health at Jacksonville | Jacksonville | Florida | 32209 | — |
| Neurology Associates, PA | Maitland | Florida | 32751-4723 | — |
| Parkinsons Disease Treatment Center of Southwest Florida | Port Charlotte | Florida | 33980 | — |
| Suncoast Neuroscience Associates | St. Petersburg | Florida | 33713-8844 | — |
| Infinity Clinical Research, LLC | Sunrise | Florida | 33351 | — |
| USF Health Parkinson's Disease and Movement Disorders | Tampa | Florida | 33613 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Unity Point Health | Des Moines | Iowa | 50309 | — |
| University of Maryland, Neurology | Baltimore | Maryland | 21201 | — |
| QUEST Research Institute | Farmington Hills | Michigan | 48334 | — |
| Henry Ford Hospital | West Bloomfield | Michigan | 48322-3013 | — |
| Pyramid Clinical Research | Somerset | New Jersey | 08873-3448 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| The Movement Disorder Clinic of Oklahoma | Tulsa | Oklahoma | 74136 | — |
| Synergy Trials | Richmond | Virginia | 23226 | — |
| Sentara Neuroscience Institute | Virginia Beach | Virginia | 23456-0168 | — |
| Premier Research | Spokane | Washington | 99202-1461 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02726386, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2025 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02726386 live on ClinicalTrials.gov.